Lab Corp for some diagnostic assets related to biowantic health, almost a year after the contract attacked, Lab testing has returned to the giant Buy firm cancer tests.
According to the financial terms announced last week, the lab carp is paying for the Biirens’ Oncology Testing Business .5 192.5 million. Another .5 is associated with 32.5 million performance goals that were not disclosed. In this acquisition, bioreans extends on the oncology and oncology clinical testing services that are developed directly for therapists, genetic experts, hospitals, clinics, corrective facilities and other health services.
Biirence is a subsidiary of Opco Health based in Miami. The company’s low income resulted in a loss of $ 86.7 million in 2024. Opco is smooth its operations in an attempt to promote the company’s lower line. This strategy includes reducing costs in bauroughs.
Last March, Opco reached a $ 237.5 million contract to sell its clinical diagnosis and reproductive women’s health business to a lab carp. Annual revenue in this business had about $ 100 million. According to companies, the oncology testing business is now ready to go to the lab carp, according to companies, according to companies, annual revenue generates about $ 85 million to $ 100 million.
“This transaction with the Lab Corp, with the Lab Corp, represents another important step in furthering the profit for Opco -Health,” Opco Chairman and CEO Philip Frost said.
Its acquisition is part of the lab carp development strategy in Berlinton, North Carolina, which, according to its annual report, spent $ 839 million on M&A deals in 2024. The purchase of bioreans clinical and reproductive women’s health business was closed last September. It was the second largest lab carp in 2024, behind only $ 240.8 million for some of the auctioned genetic testing assets as part of the company’s bankruptcy process.
The acquisition of Lab Corp’s biorence incology testing business is subject to traditional closing terms and applicable state regulatory approval. Companies expect the contract to be closed in the second half of 2025.
Photo: Smith Collection/Gudu through Getty Images
